Analyzing Mannatech (MTEX) and The Competition

Mannatech (NASDAQ: MTEX) is one of 43 public companies in the “Medicinals & botanicals” industry, but how does it compare to its rivals? We will compare Mannatech to similar businesses based on the strength of its institutional ownership, earnings, analyst recommendations, valuation, profitability, risk and dividends.

Volatility and Risk

Mannatech has a beta of 1.05, meaning that its share price is 5% more volatile than the S&P 500. Comparatively, Mannatech’s rivals have a beta of 1.68, meaning that their average share price is 68% more volatile than the S&P 500.

Institutional & Insider Ownership

23.4% of Mannatech shares are held by institutional investors. Comparatively, 19.1% of shares of all “Medicinals & botanicals” companies are held by institutional investors. 48.4% of Mannatech shares are held by company insiders. Comparatively, 30.3% of shares of all “Medicinals & botanicals” companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Dividends

Mannatech pays an annual dividend of $0.80 per share and has a dividend yield of 2.1%. Mannatech pays out 21.0% of its earnings in the form of a dividend. As a group, “Medicinals & botanicals” companies pay a dividend yield of 2.1% and pay out 21.0% of their earnings in the form of a dividend. Mannatech has raised its dividend for 2 consecutive years.

Profitability

This table compares Mannatech and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Mannatech 5.00% 31.54% 12.38%
Mannatech Competitors -164.96% -58.60% -11.38%

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Mannatech and its rivals, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mannatech 0 0 0 0 N/A
Mannatech Competitors 229 619 585 13 2.26

As a group, “Medicinals & botanicals” companies have a potential upside of 41.40%. Given Mannatech’s rivals higher probable upside, analysts plainly believe Mannatech has less favorable growth aspects than its rivals.

Valuation and Earnings

This table compares Mannatech and its rivals gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Mannatech $151.41 million $6.26 million 10.05
Mannatech Competitors $223.88 million -$78.74 million 3.73

Mannatech’s rivals have higher revenue, but lower earnings than Mannatech. Mannatech is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Summary

Mannatech beats its rivals on 7 of the 10 factors compared.

Mannatech Company Profile

Mannatech, Inc. develops nutritional supplements, topical and skin care products and weight-management products that target optimal health and wellness. Its product category include integrative health,targeted health, wealth and fitness, skin care, essentials, and home. The company was founded by Marlin Ray Robbins and Samuel L. Caster in November 1993 and is headquartered in Flower Mound, TX.

Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.